Class information for:
Level 1: DESOGESTREL//ORAL CONTRACEPTIVES//DROSPIRENONE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1453 2559 32.5 60%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
492 14766 CONTRACEPTION//EMERGENCY CONTRACEPTION//MEDICAL ABORTION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DESOGESTREL Author keyword 107 63% 4% 109
2 ORAL CONTRACEPTIVES Author keyword 103 25% 14% 361
3 DROSPIRENONE Author keyword 82 52% 4% 112
4 CYCLE CONTROL Author keyword 67 71% 2% 54
5 GESTODENE Author keyword 63 59% 3% 70
6 CONTRACEPTION Journal 63 11% 20% 523
7 NORGESTIMATE Author keyword 46 65% 2% 44
8 ETHINYL ESTRADIOL Author keyword 39 33% 4% 95
9 EXTENDED CYCLE Author keyword 34 93% 1% 13
10 ORAL CONTRACEPTIVE Author keyword 33 27% 4% 107

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 DESOGESTREL 107 63% 4% 109 Search DESOGESTREL Search DESOGESTREL
2 ORAL CONTRACEPTIVES 103 25% 14% 361 Search ORAL+CONTRACEPTIVES Search ORAL+CONTRACEPTIVES
3 DROSPIRENONE 82 52% 4% 112 Search DROSPIRENONE Search DROSPIRENONE
4 CYCLE CONTROL 67 71% 2% 54 Search CYCLE+CONTROL Search CYCLE+CONTROL
5 GESTODENE 63 59% 3% 70 Search GESTODENE Search GESTODENE
6 NORGESTIMATE 46 65% 2% 44 Search NORGESTIMATE Search NORGESTIMATE
7 ETHINYL ESTRADIOL 39 33% 4% 95 Search ETHINYL+ESTRADIOL Search ETHINYL+ESTRADIOL
8 EXTENDED CYCLE 34 93% 1% 13 Search EXTENDED+CYCLE Search EXTENDED+CYCLE
9 ORAL CONTRACEPTIVE 33 27% 4% 107 Search ORAL+CONTRACEPTIVE Search ORAL+CONTRACEPTIVE
10 EXTENDED REGIMEN 29 88% 1% 14 Search EXTENDED+REGIMEN Search EXTENDED+REGIMEN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 20 MU G 156 90% 3% 69
2 DESOGESTREL 131 61% 5% 137
3 G ETHINYL ESTRADIOL 92 77% 2% 63
4 ETHINYL ESTRADIOL 88 29% 10% 261
5 G ETHINYLESTRADIOL 57 95% 1% 19
6 HORMONE WITHDRAWAL SYMPTOMS 48 70% 2% 40
7 PILL FREE INTERVAL 46 75% 1% 33
8 HORMONE FREE INTERVAL 45 90% 1% 19
9 GESTODENE 43 50% 2% 62
10 PROGESTAGEN 39 38% 3% 83

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CONTRACEPTION 63 11% 20% 523

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis 2014 16 96 42%
Oral contraceptives and the risk of venous thrombosis. 2001 274 75 52%
Hormonal contraception and venous thromboembolism 2012 22 24 100%
Oral Contraceptives and Venous Thromboembolism A Systematic Review and Meta-Analysis 2012 30 68 69%
Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review 2013 9 25 88%
EVALUATION OF A NEW-GENERATION OF ORAL-CONTRACEPTIVES 1993 148 73 82%
Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis 2012 19 58 78%
Combined oral contraceptives: venous thrombosis 2014 3 95 68%
Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy - A clinical review 2004 118 85 59%
Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception 2014 2 59 85%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CLIN STAT EUROPE 4 75% 0.1% 3
2 PHARMACOKINET CLIN 4 75% 0.1% 3
3 GLOBAL CLIN STAT 3 43% 0.2% 6
4 ABT HAMOSTASIOL 3 100% 0.1% 3
5 TEVA BRANDED PHARMACEUT PROD 3 100% 0.1% 3
6 GERMAN OPERAT 2 67% 0.1% 2
7 GYNAEKOL OBSTET AFDELING 2 67% 0.1% 2
8 PHARM EPIDEMIOL 2 67% 0.1% 2
9 UNITED ELIZABETH GARRETT ANDERSON HOSP 2 67% 0.1% 2
10 CLIN DEV GYNECOL ANDROL 1 100% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000201793 CONTRACEPTION//ETONOGESTREL//NORPLANT
2 0.0000178430 ETHINYLESTRADIOL//GESTODENE//CAS 57 63 6
3 0.0000119985 TRICEPS SKINFOLD//OESTROPROGESTATIVE//
4 0.0000082490 MENSTRUAL MIGRAINE//MENSTRUALLY RELATED MIGRAINE//WOMENS HEADACHE
5 0.0000072668 UNINTENDED PREGNANCY//CONTRACEPTION//LONG ACTING REVERSIBLE CONTRACEPTION
6 0.0000064266 DANISH NURSE COHORT//EPES EPIDEMIOL//BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST
7 0.0000054535 FACTOR V LEIDEN//APC RESISTANCE//ACTIVATED PROTEIN C RESISTANCE
8 0.0000054220 HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//TIMING HYPOTHESIS
9 0.0000053067 ENDOMETRIAL SAFETY//TRIMEGESTONE//CAS 53 16 7
10 0.0000047503 17 BETA AMINOESTROGENS//PROLAME//PENTOLAME